South Sudan - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, South Sudan Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases increased 61.5% year on year. In 2019, the country was ranked number 164 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases at 66 Cases. India topped the ranking with 66,255 Cases in 2019, a growth of 13.6% compared to 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo witnessed the best average annual growth at +171.1% per year, while Croatia recorded the worst performance at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 66.00 |
| 2018 | 53.00 |
| 2017 | 32.00 |
| 2016 | 13.00 |
| 2015 | 20.00 |
Download all data from 2011 to 2019
How does South Sudan rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 160 |
#160
Sao Tome and Principe
|
72 | 2019 | +1,340.0 % | +104.8 % | View data | |
| 164 |
#164
South Sudan
|
66 | 2019 | +24.5 % | +61.5 % | View data | |
| 167 |
#167
Burundi
|
64 | 2019 | +28.0 % | +5.9 % | View data | |